Yes, Novo Nordisk the Danish healthcare company, founded in 1923, manufactures both formulations
For weight management, you may be suitable for semaglutide, tirzepatide or other GLP-1-based treatment if you have a BMI of 30 kg/m or higher, or a BMI of 27 kg/m with a weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes
They may notice a brighter and more even complexion with prolonged use
Coryell Health doesnt recommend taking GLP-1 medications if you: Are pregnant or breastfeeding Have a personal or family history of medullary thyroid cancer (MTC) Have a diagnosis of multiple endocrine neoplasia syndrome type 2 Have a history of pancreatitis Have severe gastrointestinal conditions Side effects of taking a GLP-1 medication may include: Loss of appetite Nausea and vomiting Diarrhea Dizziness Mildly increased heart rate Pancreatitis Medullary thyroid cancer (MTC) Acute kidney injury If youre unsure whether an existing condition, your personal history or your family history will not mix well with a GLP-1 medication, talk with your Coryell Health primary care provider to determine whether a GLP-1 medication is right for you

Individuals with certain medical conditionsincluding heart disease, uncontrolled high blood pressure, hyperthyroidism, glaucoma, or a history of substance abuseshould generally avoid using phentermine, as it may pose health risks or worsen existing conditions
Do not use loperamide preventively or daily